Written by rjs, MarketWatch 666This is a collection of interesting news articles about the environment and related topics published last week. This is usually a Tuesday evening regular post at GEI (but can be posted at other times).
We are stepping on Jerri-Lynn’s toes a bit, since she has been following Monsanto litigation closely. Today we are providing an update on a effort to settle a large group of pending and potential cases. The short version is that this effort, like an earlier attempt, was rejected by Federal judge in the Northern District of California. We’ve embedded his order at the end of this post.
To catch you up on this sorry story, Bayer bought Monsanto, despite its known glysophate litigation risks, as a poison pill, to make Bayer too big, and by loading up the company with a lot of debt to finance an “all cash” offer to avoid shareholder approval, too leveraged to be an attractive target to even larger companies on the prowl.